Jefferies Cuts Price Target on Akorn (AKRX) to $24; Reiterates Buy
- Unemployment Rate Drops to 4.6%
- Unusual 11 Mid-Day Movers 12/2: (ASNA) (HTBX) (REPH) Higher; (PLX) (MEMP) (DRYS) Lower
- Bond yields fall on U.S. jobs data, euro flat before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Jefferies maintained a Buy rating on Akorn (NASDAQ: AKRX), and cut the price target to $24.00 (from $35.00), following the company's 3Q earnings report. Jefferies lowered estimates as re-inspection issues create more uncertainty. Assuming a 6 month delay expected revenues from pipeline products have been cut by $30M to $55M next year and FY17 total revenues and EPS were adjusted to $1.19B and $2.46 (vs $1.22B & $2.56).
Analyst David Steinberg commented, "Q3 revs & EPS were $17M & $0.02 ahead of consensus despite higher R&D spend & lower gross margin. The results however were overshadowed by the disclosure that the Decatur plant needs to be re-inspected which could result in the delay of 10 (out of 25 expected) ANDA approvals by 1Q17 and a DOJ probe on generic drug price collusion. The sharp 18% selloff (vs 4% for XBI) does not seem fully warranted in our view particularly as AKRX was not named in the DOJ probe."
Shares of Akorn closed at $20.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Cuts Price Target on Kroger (KR) to $30 Following 3Q and Guidance
- Jefferies Raises Price Target on Zumiez, Inc. (ZUMZ) to $23 Following 3Q
- FBR Capital Cuts Price Target on Express (EXPR) Following 3Q EPS Miss
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Related EntitiesJefferies & Co, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!